ZYMOPTIQ, founded in 2019, is a France-based biotechnology startup poised to revolutionize enzyme analysis with its disruptive tools for enzyme activity assays. The company boasts a compelling slogan: "Easier, faster, cheaper enzyme activity assay to understand and control your enzymes. ππ§¬π§«π¬". Their innovative products allow for rapid, straightforward, and cost-effective enzyme characterization, making them highly attractive to industries reliant on enzyme applications.
The enzymatic solutions offered by ZYMOPTIQ are user-friendly, ready-to-use, and designed to streamline enzymatic tests efficiently. Despite being a relatively young player in the market, the firm has drawn attention thanks to its transformative potential in the biotechnology sector.
The company's most recent financing event was a Non Equity Assistance investment on 22 January 2018 from Eurasante. As the firm continues to grow, it presents a promising opportunity for investors looking to enter the biotechnology space with a focus on innovation and efficiency.